How Tiny Fat Particles Deliver Medicines Deep Into Skin
This patent describes a method for delivering medicines into the skin using special nanoparticles made of fats, which are modified to easily pass through the skin's protective layers.
Patent Number
US 8715736
Status
Active
Filing Date
April 30, 2009
Grant Date
May 6, 2014
Expiration
April 30, 2029
Claims
11
Assignee
Florida Agricultural and Mechanical University
Inventors
Mandip Singh Sachdeva, Ram Patlolla
Citations
34 forward · 4 backward
What it covers
This patent claims a special formulation for applying medicines to the skin. It uses tiny particles called nanostructured lipid carriers (NLCs) that encapsulate an active substance, like an anti-inflammatory agent (Claim 3). The surface of these NLCs is modified with a 'cell penetrating peptide' (Claim 1), which helps them get past the skin's outer barrier. These NLCs are made from a blend of solid and liquid fats that stay solid at body temperature, ensuring controlled release of the medicine. The formulation is designed to deliver the active substance specifically to the epidermis, reaching a depth of about 80 to 120 microns (Claim 1). For example, this could be used to treat conditions like psoriasis or eczema (Claim 5).
What it doesn't cover
- —Does not cover skin delivery systems that do not use nanostructured lipid carrier nanoparticles.
- —Does not cover nanoparticles that are not surface-modified with a cell penetrating peptide.
- —Does not cover formulations where the blend of solid and liquid lipids is not solid at body temperature.
- —Does not cover delivery of active substances to skin depths outside the range of 80 to 120 microns.
- —Does not cover delivery methods that do not involve topical application to the skin.
The clever bit
The truly clever part is combining nanostructured lipid carriers, which offer controlled release and stability, with cell-penetrating peptides on their surface. This dual approach allows the tiny particles to both carry the medicine effectively and actively 'pull' themselves through the tough skin barrier to a specific target depth, which was a significant challenge for topical drug delivery.
Why it matters
The skin's outermost layer, the stratum corneum, is a very effective barrier, making it difficult for many medicines to penetrate deeply enough to treat underlying conditions. This patent offers a way to overcome that barrier, allowing for more targeted and effective treatment of skin diseases. By delivering active substances precisely to the epidermis, it can reduce side effects and improve the efficacy of topical drugs for conditions like inflammation, infections, and even skin cancer.
Real-world examples
- 1.Topical anti-inflammatory creams using advanced delivery systems
- 2.Dermatological treatments for psoriasis or eczema
- 3.Targeted skin cancer therapies applied directly to the skin
- 4.Formulations for treating localized bacterial or fungal skin infections
- 5.Cosmetic products designed for enhanced ingredient penetration
Generated by PatentBrief · Not legal advice · patentbrief.org
US 8715736 · 2026